Cell destruction from intraocular use of benzalkonium chloride.
Alpar
John J
JJ
D000085:Acetates; D001548:Benzalkonium Compounds / Q000009:adverse effects*; D015715:Corneal Edema / Q000139:chemically induced*; D004338:Drug Combinations; D004348:Drug Labeling / Q000592:standards; D004728:Endothelium, Corneal / Q000187:drug effects*; D006801:Humans; D008903:Minerals; D018918:Phacoemulsification; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D012965:Sodium Chloride
D000085:Acetates; C030660:BSS solution; D001548:Benzalkonium Compounds; D004338:Drug Combinations; D008903:Minerals; D011310:Preservatives, Pharmaceutical; D012965:Sodium Chloride